🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Out of my >1,100 publications, this is one I am very proud of: Cardiovascular scholarly challenges following the Russian invasion of Ukraine, by Preethi Pirlamarla, Pierre Sabouret, Sergey Kozhukhov, Oksana Marchenko, Joseph Hill, and Mamas Mamas (free full text here:

Please share with your patients ❤️❤️

We have revised the level of evidence (LOE) grading system for ESC Clinical Practice Guidelines. Criteria are more stringent & consider the optimal study design necessary to establish evidence for recommendations. Full publication available soon

1/ Strain Imaging in Echocardiography: A powerful tool for detecting subtle myocardial dysfunction, far beyond LVEF. Here’s why it’s transforming cardiology — and how you should be using it. A thread: #CardioTwitter #Echo #FOAMed

#CardioTwitter European Society of Cardiology ES

My article reached 700 reads Achieved on March 27, 2025 Article: Management of patients with heart failure and preserved ejection fraction #CardioTwitter researchgate.net/profile/Alicja… via @researchgate

The Altshock-2 trial showed that routine early IABP plus standard care, vs. standard care only, did not significantly improve 60-day survival or successful bridging to HRT in patients with HF-CS. #ACC25 Read the full clinical trial details here: bit.ly/4c9f9su

PURSUIT: AZD0780, a novel, once-daily oral molecule inhibitor, had a robust, dose-dependent effect in ↘️ LDL-C & a favorable safety profile in pts w/ hypercholesterolemia already on background moderate- or high-intensity statin treatment. bit.ly/3XG7Oe2 #ACC25 #JACC

6. RIVAWAR Trial : Rivaroxaban was found to be as effective and safe as warfarin in resolving post myocardial infarction (MI) left ventricular (LV) thrombus at three months.

Biggest Takeaways from #ACC25 Chicago 🚨 New ACS Guidelines ❤️ Clopidogrel > Aspirin post-PCI 🧠 Oral Semaglutide ↓ CV events 🫁 Sotatercept = game-changer in PAH 🧬 siRNA drops Lp(a) by 90% 💔 IV iron: QoL↑ but no outcome win 💉 TriClip shines in TR #CardioTwitter #LBT

#CardioTwitter ❤️❤️

New kid in the block in the fight of hypercholesterolemia? #cardioTwitter

#cardioTwitter Health and Social Care Northern Ireland Belfast Trust South Eastern Trust Western Trust Northern Ireland Chest Heart & Stroke Southern Trust @he

EHRA 2025 highlights: •Key late-breaking trials •New ESC/EHRA guidelines •Practical consensus updates Clear, concise, and clinical. Read the full summary: 👇 #EHRA2025 #CardioTwitter #EPeeps

Thanks Saad Ur Rahman 🙏🙏

🌈

Dangers of using a single number to assess patients: Both EFs were around 20-25%, one patient was asymptomatic, and the other was in cardiogenic shock. Guess which one?

Supporting recommendations from the latest guideline on #cvACS, #CardioSmart’s new infographic 👇 shares the benefits of participating in a cardiac rehabilitation program, what these programs entail and where patients can access care. Learn more: bit.ly/44dAvD6 #cvRehab

🫀 Takotsubo Syndrome: An Acute Myocardial Ischaemic Syndrome 1️⃣ What is Takotsubo? Takotsubo, often called “broken-heart syndrome,” mimics a heart attack with chest pain, ECG changes, and troponin elevation—but typically without blocked arteries.

🎧 What an inspiring listen by Peder L. Myhre MD, PhD on tackling heart failure—from cutting-edge HF research to biomarker-driven care, global challenges of implementing digital health, and how Norway is reshaping participation in cardiology clinical trials. emjreviews.com/cardiology/pod…